Solid tumors following kidney transplantation in children

Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer

(2012) S. B. Campbell et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009

(2012) Pierluca Piselli et al.   EUROPEAN JOURNAL OF CANCER

Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

(2012) Sylvie Euvrard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

(2011) Eric A. Engels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

(2011) Josefina Alberú et al.   TRANSPLANTATION

Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden

(2010) J. F. Simard et al.   AMERICAN JOURNAL OF TRANSPLANTATION

De Novo Malignancy After Solid Organ Transplantation in Children

(2009) D. Debray et al.   TRANSPLANTATION PROCEEDINGS

mTOR, Cancer and Transplantation

(2008) Edward K. Geissler et al.   AMERICAN JOURNAL OF TRANSPLANTATION